Back
Insmed Vs. Phathom Pharmaceuticals Industry Stock Comparison
Buy
61
INSM
Insmed
Last Price:
73.20
Seasonality Move:
0.64%
Buy
62
PHAT
Phathom Pharmaceuticals
Last Price:
18.51
Seasonality Move:
-9.67%
Buy
61
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $74.66. The Score for INSM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $18.30. The Score for PHAT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INSM Stock Price Chart
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $18.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 52.01 | Buy |
| Chaikin Money Flow: | 957641 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.98 - 77.18) | Sell |
| Bollinger Bands (100): | (39.15 - 79.53) | Buy |
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.69 | Buy |
| Relative Strength Index (14 RSI): | 69.89 | Buy |
| Chaikin Money Flow: | -1317328 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.69 - 17.61) | Buy |
| Bollinger Bands (100): | (9.38 - 14.2) | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.99 | Buy |
| 20-day SMA: | 75.18 | Sell |
| 50-day SMA: | 74.52 | Buy |
| 200-day SMA: | 43.6 | Buy |
| 8-day EMA: | 73.59 | Buy |
| 20-day EMA: | 74.14 | Buy |
| 50-day EMA: | 71.18 | Buy |
| 200-day EMA: | 49.93 | Buy |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.08 | Buy |
| 20-day SMA: | 15.87 | Buy |
| 50-day SMA: | 13.27 | Buy |
| 200-day SMA: | 10.27 | Buy |
| 8-day EMA: | 17.97 | Buy |
| 20-day EMA: | 16.29 | Buy |
| 50-day EMA: | 14.07 | Buy |
| 200-day EMA: | 11.41 | Buy |
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.10 per share, and an increase next year of $1.11 per share.
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.54 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
Insmed Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Phathom Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||